Bristow M R, Hershberger R E, Port J D, Minobe W, Rasmussen R
Department of Medicine, University of Utah School of Medicine, Salt Lake City 84132.
Mol Pharmacol. 1989 Mar;35(3):295-303.
Prenalterol (beta 1-agonist), denopamine (beta 1-agonist), and zinterol (beta 2-agonist) were partial agonists of adenylate cyclase (AC) stimulation in human ventricular myocardium obtained from nonfailing chambers whose beta 1/beta 2 receptor subtype ratio was approximately 80/20. At a concentration less than its low affinity (beta 2) Kl, betaxolol, a highly selective beta 1-antagonist, inhibited isoproterenol (non-selective agonist), denopamine, and prenalterol stimulation of AC, indicating that isoproterenol, denopamine, and prenalterol are all capable of stimulating AC through beta 1-receptor activation. At a concentration less than its low affinity (beta 1) Kl, ICI 118,551, a highly selective beta 2-agonist, inhibited both isoproterenol and zinterol stimulation of AC, indicating that isoproterenol and zinterol stimulate AC through beta 2-receptors. Zinterol stimulation of AC was mediated entirely by beta 2-receptors, inasmuch as 10(-7) M betaxolol had no effect on the zinterol dose-response curve and ICI 118,551 produced a degree of blockade (KB = 5.2 +/- 1.6 X 10(-9) M), consistent with the beta 2-receptor Kl of the latter (2.0 +/- .4 X 10(-9) M, p, not significant). In nonfailing myocardium, analysis of beta 1 versus beta 2 stimulation by the nonselective agonist isoproterenol revealed that the numerically small (19% of the total) beta 2 fraction accounted for the majority of the total adenylate cyclase stimulation. In failing ventricular chambers with a beta 1/beta 2 receptor subtype ratio reduced from 82/19 (nonfailing) to 64/36 (p less than 0.001) and a beta 1-receptor density reduced by 61% (p less than 0.001), maximal denopamine stimulation was reduced by 49% (p less than 0.001). Moreover, in preparations from failing heart, the component of denopamine stimulation that was inhibited by 10(-7) M betaxolol (beta 1 component) was reduced by 77% (p less than 0.05). Finally, in preparations derived from failing ventricular myocardium, beta 2-receptor density was not significantly decreased, but zinterol stimulation of AC was reduced by 32% (p less than 0.05). We conclude that heart failure results in subsensitivity to both selective beta 1 and beta 2 stimulation of adenylate cyclase, with beta 1 subsensitivity due to selective beta 1 receptor down-regulation and beta 2 subsensitivity due to partial uncoupling of beta 2 receptors from subsequent events in the beta 2-adrenergic pathway.
普瑞特罗(β1 激动剂)、多巴胺丁胺(β1 激动剂)和齐特罗(β2 激动剂)是从无衰竭心腔获取的人心室心肌中腺苷酸环化酶(AC)刺激的部分激动剂,其β1/β2 受体亚型比例约为 80/20。在浓度低于其低亲和力(β2)解离常数(Kl)时,高选择性β1 拮抗剂倍他洛尔抑制异丙肾上腺素(非选择性激动剂)、多巴胺丁胺和普瑞特罗对 AC 的刺激,表明异丙肾上腺素、多巴胺丁胺和普瑞特罗都能够通过β1 受体激活来刺激 AC。在浓度低于其低亲和力(β1)Kl 时,高选择性β2 拮抗剂 ICI 118,551 抑制异丙肾上腺素和齐特罗对 AC 的刺激,表明异丙肾上腺素和齐特罗通过β2 受体刺激 AC。齐特罗对 AC 的刺激完全由β2 受体介导,因为 10⁻⁷ M 倍他洛尔对齐特罗剂量反应曲线无影响,而 ICI 118,551 产生一定程度的阻断作用(KB = 5.2 ± 1.6×10⁻⁹ M),与后者的β2 受体 Kl(2.0 ± 0.4×10⁻⁹ M,p 无显著性差异)一致。在无衰竭心肌中,通过非选择性激动剂异丙肾上腺素分析β1 与β2 刺激发现,数量上较少(占总数的 19%)的β2 部分占腺苷酸环化酶总刺激的大部分。在衰竭的心腔中,β1/β2 受体亚型比例从 82/19(无衰竭)降至 64/36(p < 0.001),β1 受体密度降低 61%(p < 0.001),多巴胺丁胺最大刺激降低 49%(p < 0.001)。此外,在衰竭心脏的制剂中,10⁻⁷ M 倍他洛尔抑制的多巴胺丁胺刺激成分(β1 成分)降低 77%(p < 0.05)。最后,在来自衰竭心室心肌的制剂中,β2 受体密度无显著降低,但齐特罗对 AC 的刺激降低 32%(p < 0.05)。我们得出结论,心力衰竭导致对腺苷酸环化酶的选择性β1 和β2 刺激均出现亚敏感性,β1 亚敏感性是由于选择性β1 受体下调,β2 亚敏感性是由于β2 受体与β2 肾上腺素能途径后续事件部分解偶联。